CSIMarket
 
Abcam Plc  (NASDAQ: ABCM)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 230
 Employees -
 Revenues (TTM) (Millions $) 362
 Net Income (TTM) (Millions $) -9
 Cash Flow (TTM) (Millions $) 187
 Capital Exp. (TTM) (Millions $) 12

Business Description


Abcam Plc is a British biotechnology company that specializes in the production and distribution of research-grade antibodies and other related products. Established in 1998, the company has become one of the leading suppliers of high-quality antibodies used in various scientific research and drug discovery applications.

Abcam offers a wide range of research tools and services to support the needs of life scientists. These include antibodies, proteins, peptides, lysates, immunoassays, and other related reagents. The company has developed a reputation for providing antibodies with high specificity and sensitivity, which are essential for accurate and reliable experimental results.

In addition to its product offerings, Abcam also provides custom antibody services, where customers can request the development of specific antibodies tailored to their research needs. The company has a strong focus on quality control, with rigorous testing and validation procedures to ensure the integrity of its products.

Abcam operates globally, serving customers in academic institutions, pharmaceutical companies, biotechnology firms, and other research organizations. The company has a strong online presence, with an e-commerce platform that allows customers to easily browse and purchase its products.

Overall, Abcam Plc is a leading supplier of research-grade antibodies and other related products, known for its high-quality offerings and commitment to supporting life science research.


   Company Address: Discovery Drive Cambridge 0
   Company Phone Number: 1223 696000   Stock Exchange / Ticker: NASDAQ ABCM


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CYRX   -1.74%    
HBIO        1.13% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio -
Working Capital Ratio -
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.04 $
Revenues (TTM) 1.57 $
Cash Flow (TTM) 0.82 $
Cash 0.53 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.33

Profitability Ratios Current
Gross Margin (MRQ) 74.79 %
Operating Margin (MRQ) -2.79 %
Net Margin (MRQ) -2.35 %
Net Cash Flow Margin (MRQ) 51.78 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.